JP2015531351A5 - - Google Patents

Download PDF

Info

Publication number
JP2015531351A5
JP2015531351A5 JP2015533237A JP2015533237A JP2015531351A5 JP 2015531351 A5 JP2015531351 A5 JP 2015531351A5 JP 2015533237 A JP2015533237 A JP 2015533237A JP 2015533237 A JP2015533237 A JP 2015533237A JP 2015531351 A5 JP2015531351 A5 JP 2015531351A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
unsubstituted
fluorophenyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015533237A
Other languages
English (en)
Japanese (ja)
Other versions
JP6469009B2 (ja
JP2015531351A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/061050 external-priority patent/WO2014047519A2/en
Publication of JP2015531351A publication Critical patent/JP2015531351A/ja
Publication of JP2015531351A5 publication Critical patent/JP2015531351A5/ja
Application granted granted Critical
Publication of JP6469009B2 publication Critical patent/JP6469009B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015533237A 2012-09-21 2013-09-20 がん処置用β−ヒドロキシラーゼ阻害剤 Expired - Fee Related JP6469009B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261704014P 2012-09-21 2012-09-21
US61/704,014 2012-09-21
PCT/US2013/061050 WO2014047519A2 (en) 2012-09-21 2013-09-20 Inhibitors of beta-hydrolase for treatment of cancer

Publications (3)

Publication Number Publication Date
JP2015531351A JP2015531351A (ja) 2015-11-02
JP2015531351A5 true JP2015531351A5 (cg-RX-API-DMAC7.html) 2016-11-10
JP6469009B2 JP6469009B2 (ja) 2019-02-13

Family

ID=50342080

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015533237A Expired - Fee Related JP6469009B2 (ja) 2012-09-21 2013-09-20 がん処置用β−ヒドロキシラーゼ阻害剤

Country Status (10)

Country Link
US (8) US9771356B2 (cg-RX-API-DMAC7.html)
EP (2) EP3345596B1 (cg-RX-API-DMAC7.html)
JP (1) JP6469009B2 (cg-RX-API-DMAC7.html)
KR (1) KR102137180B1 (cg-RX-API-DMAC7.html)
CN (2) CN104902889A (cg-RX-API-DMAC7.html)
AU (1) AU2013317791B2 (cg-RX-API-DMAC7.html)
CA (1) CA2885762C (cg-RX-API-DMAC7.html)
ES (2) ES2660822T3 (cg-RX-API-DMAC7.html)
HK (1) HK1208805A1 (cg-RX-API-DMAC7.html)
WO (2) WO2014047519A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3345596B1 (en) 2012-09-21 2021-01-20 Rhode Island Hospital Inhibitors of beta-hydrolase for treatment of cancer
WO2019012159A1 (en) * 2017-07-14 2019-01-17 Protea Biopharma N.V. METHODS AND MEANS FOR DIAGNOSING AND / OR TREATING A FATIGUE-ASSOCIATED DISEASE
WO2019246093A1 (en) * 2018-06-18 2019-12-26 Midwestern University Monoclonal antibodies targeting epitopes of asph
CN109364251A (zh) * 2018-12-06 2019-02-22 苏州大学 Tet蛋白在治疗抑郁症中的应用
CA3130396A1 (en) 2019-02-15 2020-08-20 Midwestern University Isotopically-stabilized tetronimide compounds

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD39717A (cg-RX-API-DMAC7.html)
DE39717C (de) H. LEHMANN in München, Enhuberstr. 5 part Bleistifthalter
DE3577384D1 (de) 1985-08-02 1990-06-07 Chevron Res Unkrautvertilgende 2-(oxa- oder thiaheterozyklische) 5-amino-3-oxo-4-(substituierte phenyl)-2,3-dihydrofurane.
US5314913A (en) 1992-12-08 1994-05-24 American Home Products Corporation 4- or 5-(substituted sulfonyl)methyl-3(2H)-furanones
US5698585A (en) 1995-04-13 1997-12-16 Kikkoman Corporation Pharmaceutical preparation for prevention and/or treatment for cataract
JPH09110853A (ja) * 1995-10-12 1997-04-28 Kikkoman Corp 4‐アシルオキシフラノン誘導体又はその塩及びその製造方法
UA57002C2 (uk) * 1995-10-13 2003-06-16 Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування
US5877193A (en) * 1996-07-19 1999-03-02 Hoffmann-La Roche Inc. Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
TW528755B (en) * 1996-12-24 2003-04-21 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
DE69816047T2 (de) 1997-03-14 2004-04-22 Merck Frosst Canada & Co, Kirkland (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer
US20030031670A1 (en) 1999-11-08 2003-02-13 Jack R. Wands Diagnosis and treatment of malignant neoplasms
US20050123545A1 (en) 1999-11-08 2005-06-09 Wands Jack R. Diagnosis and treatment of malignant neoplasms
US6835370B2 (en) 1999-11-08 2004-12-28 Rhode Island Hospital Diagnosis and treatment of malignant neoplasms
WO2003018575A1 (en) * 2001-08-24 2003-03-06 Wyeth Holdings Corporation 5-substituted-3(2h)-furanones useful for inhibition of farnesyl-protein transferase
US6667330B2 (en) 2002-01-31 2003-12-23 Galileo Pharmaceuticals, Inc. Furanone derivatives
AU2002950862A0 (en) 2002-08-19 2002-09-12 Biosignal Pty Ltd Furanone derivatives and methods of making same
WO2004035812A2 (en) 2002-10-16 2004-04-29 Isis Innovation Limited Asparaginyl hydroxylases and modulators thereof
ES2383115T3 (es) * 2004-01-09 2012-06-18 Eli Lilly And Company Compuestos de tiofeno y furano
US10047066B2 (en) 2007-11-30 2018-08-14 Newlink Genetics Corporation IDO inhibitors
JP5855095B2 (ja) * 2010-06-07 2016-02-09 ノボメディックス, エルエルシーNovomedix, Llc フラニル化合物およびその使用
EP3345596B1 (en) 2012-09-21 2021-01-20 Rhode Island Hospital Inhibitors of beta-hydrolase for treatment of cancer

Similar Documents

Publication Publication Date Title
EP2807164B1 (en) Imidazopyrrolidinone compounds
US8859586B2 (en) Cyclohexyl isoquinolinone compounds
AU766081B2 (en) Phthalazine derivatives for treating inflammatory diseases
US8859535B2 (en) Hydroxy substituted isoquinolinone derivatives
JP2015531351A5 (cg-RX-API-DMAC7.html)
JP2020505396A5 (cg-RX-API-DMAC7.html)
HK1245780A1 (en) Imidazopyrrolidinone compounds
RU2710743C2 (ru) Гетероциклическое соединение и содержащая его фармацевтическая композиция
WO2013080141A1 (en) Pyrazolopyrrolidine compounds
RU2012110882A (ru) Производные 6-аминохиназолина или 3-цианохинолина, способы их получения и их фармацевтические применения
WO2013173254A1 (en) Bicyclic compounds as kinases inhibitors
JPWO2013100014A1 (ja) 抗腫瘍剤の効果増強剤
EP2948451A1 (en) Substituted purinone compounds
CN110507654A (zh) 有酪氨酸激酶抑制剂的组合产品和其应用
US10195208B2 (en) Combination therapy
RU2012108423A (ru) Ацилгуанидиновые производные с азотсодержащим циклом
JP2005526794A5 (ja) ベンズイミダゾールおよびマイトジェン活性化およびrhoキナーゼ阻害剤としてのその使用
WO2016159301A1 (ja) 慢性骨髄性白血病治療剤
JP2016196411A (ja) 腫瘍治療剤
AU2019341976A1 (en) Cancer combination therapy using quinoline carboxamide derivative
WO2021097075A1 (en) Substituted isoindolonyl 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same
HK1198761B (en) Imidazopyrrolidinone compounds